MAYER ELDON C. III sold 2.7% of their position (1.66K shares) of EIGER BIOPHARMACEUTICALS, INC. on the open market
Open‑market sale worth $9.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 3/14/2022ACC: 0001567619-22-006947
Director
Since Nov 2018
-1.66K
Net shares
Net seller
$9.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.66K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.66K
Price / share
$5.60
Trade value
$9.27K
% of position
2.7%
3/14/2022
62.13K→60.47K
Total
Net shares
−1.66K
Net value
-$9.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 3/14/2022 | S · Sale | −1.66K | $5.60 | $9.27K | 2.7% | 62.13K | 60.47K |
| Total | −1.66K | -$9.27K | ||||||
Derivative Transactions0
No derivative transactions reported